S200: IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT-NAÏVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED CLL12 TRIALPetra Langerbeins,Sandra Robrecht,Pascal Nieper,Paula Cramer,Moritz Fürstenau,Othman Al-Sawaf,Anna-Maria Fink,Karl-Anton Kreuzer,Ursula Vehling-Kaiser,Eugen Tausch,Christof Schneider,Lothar Müller,Michael Eckart,Rudolf Schlag,Werner Freier,Tobias Gaska,Christina Balser,Marcel Reiser,Martina Stauch,Clemens Wendtner,Kirsten Fischer,Stephan Stilgenbauer,Barbara Eichhorst,Michael HallekHemaSphere（2023）引用 0|浏览20AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
